Keyi Ao
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum: The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer: Erratum.
Journal: International journal of biological sciences
Published: June 16, 2025
Targeted NAT10 Degradation by PROTAC NP1192 Suppresses Hypoxia-Adaptive Glycolysis and Reinvigorates CD8+ Effector T‑Cell Function for Synergistic Cancer Immunotherapy.
Journal: ACS central science
Published: May 06, 2025
A cancer theranostic nanoplatform for second near-infrared fluorescence imaging-guided carbon monoxide-sensitized mild photothermal therapy with ICD induction.
Journal: Journal of colloid and interface science
Published: December 24, 2024
YTHDF3 suppresses interferon-stimulated gene (ISG)-dependent antitumor immunity and promotes HPV carcinogenesis in cervical cancer.
Journal: Cell death & disease
Published: November 24, 2024
METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
Journal: Cancer letters
Published: September 25, 2023
The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer.
Journal: International journal of biological sciences
Published: June 15, 2023
NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 28, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026